Title of article
Management of pouch dysfunction or pouchitis with an ileoanal pouch
Author/Authors
Paolo Gionchetti، نويسنده , , Claudia Morselli، نويسنده , , Fernando Rizzello، نويسنده , , Rossella Romagnoli، نويسنده , , Massimo Campieri، نويسنده , , Gilberto Poggioli، نويسنده , , Silvio Laureti، نويسنده , , Federica Ugolini، نويسنده , , Filippo Pierangeli، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2004
Pages
14
From page
993
To page
1006
Abstract
Pouchitis, a non-specific inflammation of the ileal reservoir, is the most frequent long-term complication after pouch surgery for ulcerative colitis. Incidence rates vary widely. The etiology is still unknown, but genetic susceptibility and fecal stasis with bacterial overgrowth seem to be important factors. A clinical diagnosis should be always confirmed by endoscopy and histology, and Pouchitis Disease Activity Index (PDAI), based on clinical symptoms, endoscopic appearance and histologic findings, represents an objective and reproducible scoring system for pouchitis. The treatment of pouchitis is largely empiric given the few controlled studies available. Antibiotics, especially metronidazole and ciprofloxacin, are the therapy of choice. Chronic pouchitis occurs in about 10–15% of patients; in these cases, further diagnostic tests should be performed to exclude alternative diagnoses. Highly concentrated probiotics (VSL#3) have been shown to be effective in preventing the onset and relapse of pouchitis.
Keywords
Ciprofloxacin , Metronidazole , pouchitis , probiotics. , fecal stasis and bacterial overgrowth , pouchitis disease activity index
Journal title
Best Practice and Research Clinical Gastroenterology
Serial Year
2004
Journal title
Best Practice and Research Clinical Gastroenterology
Record number
466474
Link To Document